Improved l-Type amino acid transporter 1 (LAT1)-mediated delivery of anti-inflammatory drugs into astrocytes and microglia with reduced prostaglandin production
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Improved l-Type amino acid transporter 1 (LAT1)-mediated delivery of anti-inflammatory drugs into astrocytes and microglia with reduced prostaglandin production
Authors
Keywords
Astrocytes, -type amino acid transporter 1 (LAT1), Microglia, non-steroidal anti-inflammatory drugs (NSAIDs), Prodrugs, prostaglandin E, 2, (PGE, 2, )
Journal
INTERNATIONAL JOURNAL OF PHARMACEUTICS
Volume 601, Issue -, Pages 120565
Publisher
Elsevier BV
Online
2021-04-02
DOI
10.1016/j.ijpharm.2021.120565
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Systematic review: ibuprofen-induced liver injury
- (2020) Miguel E. Zoubek et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- L-Type amino acid transporter 1 as a target for drug delivery
- (2020) Elena Puris et al. PHARMACEUTICAL RESEARCH
- Prognostic value of LAT-1 status in solid cancer: A systematic review and meta-analysis
- (2020) Jing-jing Lu et al. PLoS One
- L-Type Amino Acid Transporter 1-Utilizing Prodrugs of Ketoprofen Can Efficiently Reduce Brain Prostaglandin Levels
- (2020) Ahmed Montaser et al. Pharmaceutics
- L-Type Amino Acid Transporter 1 Enables the Efficient Brain Delivery of Small-Sized Prodrug across the Blood–Brain Barrier and into Human and Mouse Brain Parenchymal Cells
- (2020) Ahmed B. Montaser et al. ACS Chemical Neuroscience
- L-type amino acid transporter 1 utilizing prodrugs of ferulic acid revealed structural features supporting the design of prodrugs for brain delivery
- (2019) Elena Puris et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- The L-Type Amino Acid Transporter LAT1—An Emerging Target in Cancer
- (2019) Pascal Häfliger et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Mechanistic Study on the Use of the l-Type Amino Acid Transporter 1 for Brain Intracellular Delivery of Ketoprofen via Prodrug: A Novel Approach Supporting the Development of Prodrugs for Intracellular Targets
- (2019) Elena Puris et al. MOLECULAR PHARMACEUTICS
- L-Type amino acid transporter 1 (LAT1)-utilizing prodrugs are carrier-selective despite having low affinity for organic anion transporting polypeptides (OATPs)
- (2019) Johanna Huttunen et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- l-Type Amino Acid Transporter 1 (LAT1/Lat1)-Utilizing Prodrugs Can Improve the Delivery of Drugs into Neurons, Astrocytes and Microglia
- (2019) Johanna Huttunen et al. Scientific Reports
- Alzheimer’s Disease Can Be Spared by Nonsteroidal Anti-Inflammatory Drugs
- (2018) Patrick L. McGeer et al. JOURNAL OF ALZHEIMERS DISEASE
- The Human SLC7A5 (LAT1): The Intriguing Histidine/Large Neutral Amino Acid Transporter and Its Relevance to Human Health
- (2018) Mariafrancesca Scalise et al. Frontiers in Chemistry
- Human carboxylesterases: a comprehensive review
- (2018) Dandan Wang et al. Acta Pharmaceutica Sinica B
- Identification of human, rat and mouse hydrolyzing enzymes bioconverting amino acid ester prodrug of ketoprofen
- (2018) K.M. Huttunen BIOORGANIC CHEMISTRY
- The Impact of Carboxylesterases in Drug Metabolism and Pharmacokinetics
- (2018) Li Di CURRENT DRUG METABOLISM
- Alzheimer’s Disease Phenotype or Inflammatory Insult Does Not Alter Function of L-Type Amino Acid Transporter 1 in Mouse Blood-Brain Barrier and Primary Astrocytes
- (2018) Mikko Gynther et al. PHARMACEUTICAL RESEARCH
- L-type amino acid transporter 1 utilizing prodrugs: How to achieve effective brain delivery and low systemic exposure of drugs
- (2017) Elena Puris et al. JOURNAL OF CONTROLLED RELEASE
- Disease-Induced Alterations in Brain Drug Transporters in Animal Models of Alzheimer’s Disease
- (2017) Kati-Sisko Vellonen et al. PHARMACEUTICAL RESEARCH
- Novel therapeutic approaches targeting L-type amino acid transporters for cancer treatment
- (2017) Keitaro Hayashi et al. World Journal of Gastrointestinal Oncology
- Prevention of Renal Complications Induced by Non- Steroidal Anti-Inflammatory Drugs
- (2016) Sonja Vu|kovi| et al. CURRENT MEDICINAL CHEMISTRY
- Pyrrolidine dithiocarbamate activates the Nrf2 pathway in astrocytes
- (2016) Jeffrey R. Liddell et al. Journal of Neuroinflammation
- Systemic and Brain Pharmacokinetics of Perforin Inhibitor Prodrugs
- (2016) Mikko Gynther et al. MOLECULAR PHARMACEUTICS
- Amino Acid Promoieties Alter Valproic Acid Pharmacokinetics and Enable Extended Brain Exposure
- (2016) Mikko Gynther et al. NEUROCHEMICAL RESEARCH
- LAT1 Is a Critical Transporter of Essential Amino Acids for Immune Reactions in Activated Human T Cells
- (2013) K. Hayashi et al. JOURNAL OF IMMUNOLOGY
- Design, Synthesis and Brain Uptake of LAT1-Targeted Amino Acid Prodrugs of Dopamine
- (2013) Lauri Peura et al. PHARMACEUTICAL RESEARCH
- The Role of Human Carboxylesterases in Drug Metabolism: Have We Overlooked Their Importance?
- (2013) S. Casey Laizure et al. PHARMACOTHERAPY
- Covalent inhibition of recombinant human carboxylesterase 1 and 2 and monoacylglycerol lipase by the carbamates JZL184 and URB597
- (2012) J. Allen Crow et al. BIOCHEMICAL PHARMACOLOGY
- Evaluation of the interaction between nonsteroidal anti-inflammatory drugs and methotrexate using human organic anion transporter 3-transfected cells
- (2008) Akimitsu Maeda et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Protective effects of NSAIDs on the development of Alzheimer disease
- (2008) Steven C. Vlad et al. NEUROLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started